Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 5 | |
Outperform | 6 | |
Hold | 4 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 13 analysts offering 12 month price targets for BIO-TECHNE Corp have a median target of 85.00, with a high estimate of 95.00 and a low estimate of 75.00. The median estimate represents a 19.25% increase from the last price of 71.28.
High | 33.3% | 95.00 |
Med | 19.2% | 85.00 |
Low | 5.2% | 75.00 |
Dividends in USD
Div growth (TTM) | 0.00% |
---|
More ▼
Earnings history & estimates in USD
The next earnings announcement is expected on Jan 30, 2025.
Average growth rate | +1.34% |
Average growth rate | +13.79% |
More ▼
Revenue history & estimates in USD
Average growth rate | +1.30% |
Average growth rate | +12.39% |
More ▼